MedPage Today on MSN
The latest on emerging therapies for metastatic HR+/HER2- breast cancer
Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease ...
SHRM faced a discrimination claim and sent a novice investigator without adequate training. Your company probably does the ...
These breach case studies reveal cybercriminals are messy, conflicted and recruiting openly. Understanding their motives is ...
There’s a misconception throughout the country that non-compete agreements are unenforceable everywhere, and the reality is, ...
The student-developed tool provides case study prompts for business students to improve their critical thinking and reduce ...
Front-line workers make up 70% of the U.S. workforce, but they are increasingly difficult to find, train and retain, according to an analysis by HR advisory firm The Josh Bersin Co. in collaboration ...
HR executives are turning to AI to address the ongoing hiring crisis, according to new research from Google and Ipsos. Execs are using the technology to identify top candidates and skills gaps. At the ...
A human resources executive named in an ongoing workplace discrimination lawsuit against Baltimore Gas and Electric and parent company Exelon plans to retire, just months after BGE replaced its CEO, ...
A phase 2 study evaluates linvoseltamab's safety and efficacy in high-risk smoldering myeloma, focusing on response rates and MRD negativity. In an interview with Targeted Oncology, Paula Rodriguez ...
Marcus Patel felt a mixture of pride and unease as he stood at the head of the conference table, waiting for his leadership team to gather. Two years ago he’d been recruited from Silicon Valley to ...
Small and mid-sized business leaders often view HR tech as a cost center and don’t prioritize investing in it. To convince them otherwise, HR managers must advocate not for the people side of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results